These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. QTc interval screening for cardiac risk in methadone treatment of opioid dependence. Pani PP; Trogu E; Maremmani I; Pacini M Cochrane Database Syst Rev; 2013 Jun; (6):CD008939. PubMed ID: 23787716 [TBL] [Abstract][Full Text] [Related]
23. QTc prolongation in methadone maintenance--the role of HCV infection. Gholami N; Boesch L; Falcato L; Stohler R; Bruggmann P Swiss Med Wkly; 2013; 143():w13852. PubMed ID: 24018830 [TBL] [Abstract][Full Text] [Related]
24. Cocaine-related torsade de pointes in a methadone maintenance patient. Krantz MJ; Rowan SB; Mehler PS J Addict Dis; 2005; 24(1):53-60. PubMed ID: 15774410 [TBL] [Abstract][Full Text] [Related]
25. Methadone and torsade de pointes: case report and review of the literature. Iskandar SB; Abi-Saleh BS; Mechleb BK; Fahrig SA Tenn Med; 2007 Feb; 100(2):35-7, 42. PubMed ID: 17378505 [TBL] [Abstract][Full Text] [Related]
26. Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes. Krantz MJ; Garcia JA; Mehler PS Pharmacotherapy; 2005 Apr; 25(4):611-4. PubMed ID: 15977920 [TBL] [Abstract][Full Text] [Related]
27. [Routine ECG in methadone-assisted rehabilitation is wrong prioritization]. Krook AL; Waal H; Hansteen V Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2940-1. PubMed ID: 15550974 [TBL] [Abstract][Full Text] [Related]
28. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations. Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592 [TBL] [Abstract][Full Text] [Related]
29. Torsades de pointes with methadone. Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343 [TBL] [Abstract][Full Text] [Related]
30. QTc interval prolongation in patients on long-term methadone maintenance therapy. Maremmani I; Pacini M; Cesaroni C; Lovrecic M; Perugi G; Tagliamonte A Eur Addict Res; 2005; 11(1):44-9. PubMed ID: 15608471 [TBL] [Abstract][Full Text] [Related]
31. [Torsade de pointes: a severe and unknown adverse effect in a patient taking methadone]. Vodoz JF; Jaquier F; Lamy O Praxis (Bern 1994); 2003 Oct; 92(41):1748-50. PubMed ID: 14587370 [TBL] [Abstract][Full Text] [Related]
32. [Torsade de Pointes in patient infected with human immunodeficiency virus and treated with methadone]. Moral Moral P; Rueda Soriano J; Tasias Pitarch M; Calbuig Alborch JR An Med Interna; 2006 Aug; 23(8):397-8. PubMed ID: 17089463 [No Abstract] [Full Text] [Related]
33. Phenytoin in Treatment of Methadone-Induced Torsades de Pointes: A Case Report. Altheeb Z; Alziadat M; Shamoon F Am J Ther; 2017; 24(5):e634-e636. PubMed ID: 27754988 [No Abstract] [Full Text] [Related]
34. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Fanoe S; Hvidt C; Ege P; Jensen GB Heart; 2007 Sep; 93(9):1051-5. PubMed ID: 17344330 [TBL] [Abstract][Full Text] [Related]
39. Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting. Marill KA; Miller ES J Electrocardiol; 2017; 50(4):416-423. PubMed ID: 28274542 [TBL] [Abstract][Full Text] [Related]
40. Methadone induced torsade de pointes in a patient receiving antiretroviral therapy. Falconer M; Molloy D; Ingerhaug J; Barry M Ir Med J; 2007; 100(10):631-2. PubMed ID: 18277734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]